Dow Down0.22% Nasdaq Up0.14%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
1.37 Down 0.03(2.14%) Aug 22, 3:59PM EDT
|After Hours : 1.37 0.00 (0.00%) Aug 22, 4:27PM EDT
ProfileGet Profile for:
Cytori Therapeutics, Inc.
3020 Callan Road
San Diego, CA 92121
United States - Map
Phone: 858-458-0900
Fax: 858-458-0994
Website: http://www.cytori.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:115

Business Summary 

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. It primarily provides the Celution System, a tissue processing system that automates the process of digesting fat tissue, releasing the ADRCs. The company also offers the StemSource Cell Bank, a suite of products to allow hospitals or tissue banks to cryopreserve adipose-derived stem and regenerative cells; and StemSource 900/MB, a research laboratory equipment. Its products also include Celution 800 System that has CE Mark approval for certain soft tissue procedures, such as breast reconstruction, tissue ischemia, deficiency or injury of skin, fat, and muscle and fascia, as well as soft tissue wounds or fistulae associated with trauma, diabetes, ischemia, and radiation injury. In addition, Cytori Therapeutics, Inc. develops products in therapeutic areas, such as the treatment of thermal burns, and orthopedics and sports medicine indications, as well as specifically heart failure due to ischemic heart disease. The company markets its systems, instrumentations, and consumables directly, as well as through a network of distributors to hospitals, clinics, tissue banks, stem cell banking companies, and researchers performing investigator-initiated and funded studies worldwide. Cytori Therapeutics, Inc. was founded in 1996 and is headquartered in San Diego, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Cytori Therapeutics, Inc.

Corporate Governance 
Cytori Therapeutics, Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 5. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 2; Compensation: 8.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Dr. Marc H. Hedrick M.D., 51
Chief Exec. Officer, Pres, Principal Financial Officer, Director and Member of Exec. Committee
495.00K0.00
Mr. Clyde W. Shores , 54
Exec. VP of Marketing & Sales
389.00K0.00
Dr. Steven Kesten M.D., 56
Chief Medical Officer and Exec. VP
515.00K0.00
Mr. Mark E. Saad , 44
Consultant
425.00K0.00
Dr. Douglas M. Arm Ph.D., 45
Sr. VP of Operations
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders